Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 11,804 | 11,086 | 14,420 | 8,348 | 8,402 |
| Cost of Goods | 5,975 | 5,100 | 4,708 | 3,675 | 5,423 |
| Gross Profit | 5,828 | 5,986 | 9,712 | 4,673 | 2,980 |
| Operating Expenses | 13,295 | 11,853 | 11,882 | 12,090 | 13,442 |
| Operating Income | -6,491 | -5,768 | -1,462 | -6,742 | -10,040 |
| Other Income | 39 | 30 | -45 | -46 | -8 |
| Pre-tax Income | -6,452 | -5,738 | -1,507 | -6,788 | -10,048 |
| Net Income Continuous | -6,627 | -5,738 | -1,507 | -6,788 | -10,073 |
| Net Income | $-6,627 | $-5,738 | $-1,507 | $-6,788 | $-10,073 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.01 | -0.05 | -0.08 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.01 | -0.05 | -0.08 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.01 | -0.05 | -0.08 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.01 | -0.05 | -0.08 |
| EBITDA(a) | $-6,088 | $-5,364 | $-1,069 | $-6,362 | $-9,688 |